Skip to Content

New Ebola Test Produces Results in Remote Areas

FRIDAY, Nov. 9, 2018 -- The U.S. Food and Drug Administration has approved emergency use of a new Ebola fingerstick test, which includes a reader that makes it possible to obtain results outside a laboratory.

The DPP Ebola Antigen System makes obtaining test results possible in remote areas with limited lab resources, such as those in African nations affected by Ebola outbreaks, the agency said Friday in a news release.

"The scourge of Ebola tragically demonstrates that we're a global community when it comes to public health protection. Infectious disease doesn't recognize nation states," said FDA Commissioner Dr. Scott Gottlieb.

The emergency declaration permitting the test's use was made in response to an Ebola outbreak in the central-African nation of the Congo, the FDA said.

The agency cautioned that test results shouldn't be the only criterion used to determine a patient's course of treatment. Medical professionals also should consider a patient's history, vital signs, symptoms and likelihood of exposure, the FDA said.

The test is produced by Chembio Diagnostic Systems, based in Medford, N.Y.

© 2020 HealthDay. All rights reserved.

Posted: November 2018

Read this next

'Weekend Effect' Affects Survival Odds for Rural Stroke Patients

WEDNESDAY, Oct. 21, 2020 -- Stroke patients have a higher risk of death if they're admitted to a rural hospital on the weekend, a new study finds. University of Georgia...

Pancreas Cells That Drive Type 1 Diabetes Appear in Healthy People, Too

WEDNESDAY, Oct. 21, 2020 -- Scientists knew that dangerous T-cells lived in the pancreases of people with type 1 diabetes, but a new study shows they also take up residence in the...

New Wave of COVID Infections Taking Hold in America

WEDNESDAY, Oct. 21, 2020 -- A third surge of coronavirus cases now has a firm grip on the United States, with an average of 59,000 new infections being reported across the country...